Ampliphi Biosciences Corp Stock Nyse
Equities
APHB
US03211P2020
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 4.54M | Sales 2025 * | 2.75M | Capitalization | 108M |
---|---|---|---|---|---|
Net income 2024 * | -72M | Net income 2025 * | -67M | EV / Sales 2024 * | 23.7 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 39.2 x |
P/E ratio 2024 * |
-1.56
x | P/E ratio 2025 * |
-2.29
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 29.7% |
Managers | Title | Age | Since |
---|---|---|---|
Deborah Birx
CEO | Chief Executive Officer | 68 | 23-07-10 |
Richard Rychlik
DFI | Director of Finance/CFO | 68 | 23-09-04 |
Mina Pastagia
CTO | Chief Tech/Sci/R&D Officer | - | 20-10-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 20-02-11 | |
Joseph Patti
BRD | Director/Board Member | 60 | 19-05-08 |
Jules Haimovitz
BRD | Director/Board Member | 73 | 21-03-31 |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 46.56B | |
+45.38% | 41.67B | |
+0.69% | 41.16B | |
+30.52% | 32.4B | |
+22.30% | 28.18B | |
-6.35% | 28.1B | |
+49.25% | 14.52B | |
+49.18% | 13.74B | |
+3.45% | 12.17B |